[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condbio:rectal-adenocarcinoma:mrc1-wt-allele":3},{"condition":4,"biomarker":5,"total":6,"trials":7},"Rectal Adenocarcinoma","MRC1 wt Allele",5,[8,16,22,28,34],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT06843434","A Study of Botensilimab and Balstilimab for Rectal Adenocarcinoma",[12],"Phase 2","RECRUITING","2026-08-26T02:15:22.311223Z","2026-07-05T05:32:16.700719Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT05672524","A Study of Tucatinib and Trastuzumab in People With Rectal Cancer",[12],"2026-08-26T02:17:00.709807Z","2026-05-05T02:43:29.285490Z",{"nct_id":23,"title":24,"phases":25,"status":13,"updated_at":26,"content_modified":27},"NCT07292298","Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates",[12],"2026-08-26T02:18:53.782384Z","2026-05-05T02:43:27.930465Z",{"nct_id":29,"title":30,"phases":31,"status":13,"updated_at":32,"content_modified":33},"NCT06529523","Tislelizumab in People With Colorectal Cancer",[12],"2026-08-26T02:15:31.806698Z","2026-05-05T02:43:27.088777Z",{"nct_id":35,"title":36,"phases":37,"status":13,"updated_at":38,"content_modified":39},"NCT04165772","Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors",[12],"2026-08-26T02:19:11.399072Z","2026-07-05T05:32:16.775552Z"]